The clinical utility of brain natriuretic peptide in paediatric left ventricular failure

European Journal of Heart Failure

Volumn 11, Issue 1, 2009, Pages 48-52

  Mangat, Jasveer ^a   Carter, Catherine ^a   Riley, Gillian ^a   Foo, Ying ^a   Burch, Michael ^a  

^a GREAT ORMOND STREET HOSPITAL   (United Kingdom)

Author keywords

BNP; Brain natriuretic peptide; Dilated cardiomyopathy; Heart failure

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE FAILURE; HEART TRANSPLANTATION; HUMAN; INFANT; MALE; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; TISSUE DOPPLER IMAGING; ANALYSIS OF VARIANCE; BLOOD; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; MORTALITY; RETROSPECTIVE STUDY; ROC CURVE; SURVIVAL;

ADOLESCENT; ANALYSIS OF VARIANCE; CHILD; CHILD, PRESCHOOL; FEMALE; HEART FAILURE; HUMANS; INFANT; MALE; NATRIURETIC PEPTIDE, BRAIN; RETROSPECTIVE STUDIES; ROC CURVE; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 62449258500     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1093/eurjhf/hfn001     Document Type: Article

References (28)

1. Ruskoaio I. Cardiac hormones as diagnostic tools in heart failure. Endocr Rev 2003; 24:3441-3356.
2. Nakagawa O, Ogawa Y, Itoh H, Suga S, Komatsu Y, Kishimoto I, Nishino K, Yoshimasa T, Nakao K. Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy: evidence for brain natriuretic peptide as an 'emergency' cardiac hormone against ventricular overload. J Clin Invest 1995;96:1280-1287.
3. Hama N, Itoh H, Shirakami G, Nakagawa O, Suga S, Ogawa Y, Masuda I, Nakanishi K, Yoshimasa T, Hashimoto Y, Yamaguchi M, Hori R, Yasue H, Nakao K. Rapid ventricular induction of brain natriuretic peptide gene expression in experimental acute myocardial infarction. Circulation 1995;92:1558-1564.
4. Lim P, Monin J, Monchi M, Garot J, Pasquet A, Hittinger L, Vanoverschelde J, Carayon A, Gueret P. Predictors of outcome in patients with severe aortic stenosis and normal left ventricular function: role of B-type natriuretic peptide. Eur Heart J 2004;25:2048-2053.
5. Cowie M, Wood D, Coats A, Thompson S, Poole-Wilson P, Suresh V, Sutton G. Incidence and aetiology of heart failure: a population-based study. Eur Heart J 1999;20:421-428.
6. Nugent A, Daubeney P, Chondros P, Carlin J, Cheung M, Wilkinson L, Davis A, Kahler S, Chow C, Wilkinson J, Weintraub R, the National Australian Childhood Cardiomyopathy Study. The epidemiology of childhood cardiomyopathy in Australia. N Engl J Med 2003;348:1639-1646.
7. Lipshultz S, Sleeper L, Towbin J, Lowe A, Orav E, Cox G, Lurie P, McCoy K, McDonald M, Messere J, Colan S. The incidence of pediatric cardiomyopathy in two regions of the United States. N Engl J Med 2003;348:1647-1655.
8. Yoshibayashi M, Kamiya T, Saito Y, Nakao K, Nishioka K, Temma S, Itoh H, Shirakami G, Matsuo H. Plasma brain natriuretic peptide concentrations in healthy children from birth to adolescence: marked and rapid increase after birth. EurJ Endocrinol 1995;133:207-209.
9. Koch A, Singer H. Normal values of B type natriuretic peptide in infants, children, and adolescents. Heart 2003;89:875-878.
10. Price JF, Thomas AK, Grenier M, Eidem BW, O'Brian Smith E, Denfield S, Towbin JA, Dreyer WJ. B-type natriuretic peptide predicts adverse cardiovascular events in paediatric outpatients with chronic left ventricular systolic dysfunction. Circulation 2006;114:1063-1069.
11. Ohuchi H, Takasugi H, Ohashi H, Okada Y, Yamada O, Ono Y, Yagihara T, Echigo S. Stratification of pediatric heart failure on the basis of neurohormonal and cardiac autonomic nervous activities in patients with congenital heart disease. Circulation 2003;108:2368-2376.
12. Maisel AS, Krishnaswamy P, Nowak RM, McCord J, Hollander JE, Duc P, Omland T, Storrow AB, Abraham WT, Wu AH, Clopton P, Steg PG, Westheim A, Knudsen CW, Perez A, Kazanegra R, Herrman HC, McCullough PA, for the Breathing Not Properly Multinational Study Investigators. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 2002;347:161-167.
13. Berger R, Huelsman M, Strecker K, Bojic A, Moser P, Stanek B, Pacher R. B-type natriuretic peptide predicts sudden death in patients with chronic heart failure. Circulation 2002;105:2392-2397.
14. Koglin J, Pehlivanli S, Schwaiblmair M, Vogeser M, Cremer P, vonScheidt W. Role of brain natriuretic peptide in risk stratification of patients with congestive heart failure. J Am Coll Cardiol 2001;38:1934-1941.
15. The Criteria Committee of the New York Heart Association. Diseases of the Heart and Blood Vessels: Nomenclature and Criteria for Diagnosis. 6th ed. Boston: Little, Brown & Co.; 1964. p112.
16. Ross R, Bollinger R, Pinsky W. Grading the severity of heart failure in infants. Pediatr Cardiol 1992;13:72-75.
17. Rosenthal D, Chrisant MR, Edens E, Mahony L, Canter C, Colan S, Dubin A, Lamour J, Ross R, Shaddy R, Addonizio L, Beerman L, Berger S, Bernstein D, Blume E, Boucek M, Checchia P, Dipchand A, Drummond-Webb J, Fricker J, Friedman R, Hallowell S, Jaquiss R, Mital S, Pahl E, Pearce B, Rhodes L, Rotondo K, Rusconi P, Scheel J, Pal Singh T, Towbin J. International Society for Heart and Lung Transplantation: Practice guidelines for management of heart failure in children. J Heart Lung Transplant 2004;23:1313-1333.
18. First T, Skovranek J, Marek J. Normal Values of two-dimensional echocardio-graphic parameters in children. Cesk Pediatr 1992;47:260-264.
19. Vogeser M, Jacob K. B-type natriuretic peptide (BNP) - validation of an immediate response assay. Clin Lab 2001;47:29-33.
20. Maisel A, Hollander J, Guss D, McCullough P, Nowak R, Green G, Saltzberg M, Ellison SR, Bhalla MA, Bhalla V, Clopton P, Jesse R. Primary results of the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT): a multicenter study of B-type natriuretic peptide levels, emergency department decision making, and outcomes in patients presenting with shortness of breath. J Am Coll Cardiol 2004;44:1328-1333.
21. Kruger S, Graf J, Kunz D, Stickel T, Hanrath P, Janssens U. Brain natriuretic peptide levels predict functional capacity in patients with chronic heart failure. J Am Coll Cardiol 2002;40:718-722.
22. Watanabe J, Shiba N, Shinozaki T, Koseki Y, Karibe A, Komaru T, Miura M, Fukuchi M, Fukahori K, Sakuma M, Kagaya Y, Shirato K. Prognostic value of plasma brain natriuretic peptide combined with left ventricular dimensions in predicting sudden death of patients with chronic heart failure. J Card Fail 2005;11: 50-55.
23. Westerlind A, Wahlander H, Lindstedt G, Lundberg PA, Homgren D. Clinical signs of heart failure are associated with increased levels of natriuretic peptide types B and A in children with congenital heart defects or cardiomyopathy. Acta Paediatr 2004;93:340-345.
24. Koulouri S, Acherman RJ, Wong PC, Chang LS, Lewis AB. Utility of B-type natriuretic peptide in differentiating congestive heart failure from lung disease in pediatric patients with respiratory distress. Pediatr Cardiol 2004;25:341-346.
25. Koch A, Zink S, Singer H. B-type natriuretic peptide in paediatric patients with congenital heart disease. Eur Heart J 2006;27:861- 866.
26. Law Y, Keller B, Feingold B, Boyle G. Usefulness of plasma B-type natriuretic peptide to identify ventricular dysfunction in pediatric and adult patients with congenital heart disease. Am J Cardiol 2005;95:474- 478.
27. Dokainish H, Zoghbi WA, Lakkis NM, Quinones MA, Nagueh SF. Comparative accuracy of B-type natriuretic peptide and tissue Doppler echocardiography in the diagnosis of congestive heart failure. AmJ Cardiol 2004;93:1130-1135.
28. Dokainish H, Zoghbi WA, Lakkis NM, Ambriz EA, Patel R, Quinones MA, Nagueh SF. Incremental predictive power of B-type natriuretic peptide and tissue Doppler echocardiography in the prognosis of patients with congestive heart failure. J Am Coll Cardiol 2005;45:1223-1226.